0% found this document useful (0 votes)
14 views26 pages

1_Neuralink

The document explores Neuralink technology, focusing on its development as a brain-computer interface aimed at assisting individuals with neurological disorders and enhancing cognitive abilities. It discusses the company's history, key milestones, ethical considerations, and potential benefits and risks associated with the technology. Additionally, it highlights the technical challenges faced by Neuralink and similar companies in creating safe and effective brain implants.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
14 views26 pages

1_Neuralink

The document explores Neuralink technology, focusing on its development as a brain-computer interface aimed at assisting individuals with neurological disorders and enhancing cognitive abilities. It discusses the company's history, key milestones, ethical considerations, and potential benefits and risks associated with the technology. Additionally, it highlights the technical challenges faced by Neuralink and similar companies in creating safe and effective brain implants.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 26

EXPLORING THE POTENTIAL AND IMPLICATIONS OF

NEURALINK TECHNOLOGY

Team Leader: BLESSYL C. LAROZA Date: OCTOBER 3, 2023

Members:

BEGAYO, REYMARK

MACABANTE, TANAH ANDREA

ORIGEN, ANNELYN

PALLAR, DANNEL EARLSOPHIE

A. Background Information on Neuralink

a. Overview of Brain-Computer Interface (BCI) Technology

The Brain-Computer Interfaces (BCI), also called the Brain Machine

Interface (BMI) (Nicolas-Alonso & Gomez-Gil, 2012), is a set of

technologies that are seen to be helpful in assisting individuals who are

non-communicative or paralyzed. This can directly detect brain activity,

provide feedback and responses in real-time, classify brain activity, and

provide feedback on whether the user has successfully attained a goal

(Burwell et al., 2017). This can be done with the help of external devices

such as computers, speech synthesizers, assistive appliances, and neutral

prostheses (Nicolas-Alonso & Gomez-Gil, 2012). As stated in the studies,

this particular technology is considered to rehabilitate subjects with motor

impairments and increase human working capacity (Saha et al., 2021).

b. History and Development of Neuralink


Neuralink is an Elon Musk neurotechnology company that is trying to

develop a brain chip that would help paralyzed or blind individuals (Reuters,

2022). It was founded in 2016, publicly introduced in 2017 through the Wall

Street Journal, and publicly announced by Elon Musk in 2019. Dating back

to 2015, Neuralink is owned by Pedram Mohseni, an electrical engineer

who at that time is building his own start-up company with his partner,

Randolph Nudo. The goal of this creation is to help people with brain

injuries however, the financial obstacle they have faced led them to accept

an offer for their company which happened to be the doing of Elon Musk

(Barton, 2021). As a starting point for Neuralink’s technology, the company

has developed The Link, Neuralink’s brain-machine interface device, which

is a small chip implanted in the skull and is connected wireless to a small

computer worn behind the ear allowing a connection to the internet and

other devices and uses small electrodes to record the electrical activity of

the brain. To implant the chip, a robotic surgical system is currently being

developed to place electrodes safely and avoid any injury. This technology

has been tested using animals particularly monkeys and is seen to make

monkeys capable of grasping and communicating (FindLight, 2023).

c. Key Milestones and Achievements of Neuralink

Neuralink, a neurotechnology company that aims to develop

implantable brain-computer interfaces has reached its key milestone as it

has received an approval on the first-in-human clinical study from the US

Food and Drug Administration (Dixit, 2023). This is an achievement since in

the early 2022, its request for permission was rejected due to numerous
issues that are harmful to human subjects (Sekuterski, n.d.). With this, the

company will now be able to extend help to individuals with paralysis and

spinal cord injuries and restore mobility and independence (TT Consultants,

2023).

d. Ethical and Societal Consideration Related to BCI

Most of the studies conducted have stated that the Brain-Computer

Interface has several ethical and societal issues that must be considered.

This includes the consideration of the safety of the users given that it is a

new biomedical device. It may pose a direct risk of harm, may cause

infection, and may affect the neural tissue. This is supported by the findings

in the study of the NC State University (2020) as risks in surgeries,

infection, and glial scarring are expected. Another is related to humanity

and personhood, stigma and normality, autonomy, responsibility, research

ethics and informed consent, privacy and security, and possible changes in

the social norms (Burwell, 2017). Finally, some BCIs are costly, a burden,

and harmful if inaccurate (US Government Accountability Office, 2022).

A. Discuss how Neuralink technology can benefit individuals with

neurological disorders

A neurotechnology company operations called Neuralink is improving

the field of neuroscience and neuroengineering, according to the paper

written by Fiani et al. (2021). Its goal is to create an implanted

brain-machine interface device that will improve the lives of patients who

have suffered serious neurological disorders and spinal cord injuries.

Brain-computer interfaces can identify variations and track brain activity


that may assess neurological disorders which include epilepsy, bipolar

disorder, obsessive-compulsive disorder, and Alzheimer's, or Parkinson's

disease. According to Becher (2023), the Neuralink website states that

recovering motor, sensory, and visual functions and treating neurological

disorders is their primary goal. In line with this, some sources have stated

that Neuralink will enable rapid surgical insertions of its chip devices to cure

disorders such as obesity, autism, depression, and schizophrenia (Capoot,

2022).

An article Neuralink’s Milestone 2023 states that these Neuralink brain

implants could assist people with neurological disorders to lessen

symptoms, recover lost functionality, and improve their cognitive abilities by

directly stimulating specific brain regions. As a result, Neuralink's

technology enables cognitive enhancement and improves the quality of life

for people with neurological disorders (Hashmi, 2023)

B. Present case studies or examples of successful applications

Moore (2023) stated that Neuralink's first effort at obtaining FDA

approval in 2022 was rejected on safety concerns, according to an

exclusive Reuters report. As reported by Levy (2022), Elon Musk's idea has

killed an estimated 1,500 animals since 2018, including sheep, pigs, and

monkeys. On the other hand, Musk announced that Neuralink had gotten

approval from the US Food and Drug Administration (FDA) to begin its

first-in-human clinical research, an important accomplishment following

previous failures to obtain approval as emphasized in the statement of the

Physicians Committee.
In a statement to Reuters, the FDA admitted that it has allowed

Neuralink to utilize its brain implant and surgical robot for studies, but

declined to disclose any additional information (Levy et al., 2023).

Neuralink's brain-computer interface will necessitate extensive brain

surgery on patients (Capoot, 2023). Its system revolves around the Link, a

tiny circular implant that analyses and transmits neural data. The Link is

linked to a network of thin, flexible threads that are put directly into brain

tissue for detecting neural signals (Hart, n.d.). According to investigations,

Neuralink has successfully tested portions of its technology on animals,

including a video in 2021 of a monkey playing a basic video game after

being implanted with a brain chip (Wakefield, 2021). Moreover, utilizing the

chip for controlling a robotic arm, monkeys were programmed to execute

tasks like reaching for and gripping objects, and restoring motor function to

those who have paralysis. The chip was even utilized to translate brain

activity into speech in monkeys, which serves as a first step toward

assisting individuals with speech difficulties with communication. According

to BBC 2020 news report, Elon Musk has also introduced Gertrude, a pig

with a coin-sized computer chip in her brain, to demonstrate his eager

intentions to establish a functional brain-to-machine interface. When the pig

is seeking food, its brain's processor sends wireless signals signaling

neuronal activity in its snout.

Lastly, research suggests that by using BMIs, NeuraLink technology

advances towards ultra-high bandwidth technology. Brain-Machine

Interfaces (BMIs) have the potential for the recovery of sensory and motor

function as well as the treatment of neurological conditions, however,


clinical BMIs have yet to be extensively embraced, in part because of their

limited channel capacities (Sood & Mishra, 2020).

C. Explore the current state of Neuralink’s medical research

By connecting brains to computers, the Neuralink implant operations

intend to help people regain vision and mobility. However, experts have

warned that if Neuralink's brain implants are to become generally available,

they will need significant testing to solve technical and ethical constraints

(FitzGerald, 2023). To some extent, only predictions about the device's

safety and efficacy can be made. The scarcity of data necessitates deeper

analysis and research. Furthermore, clinical studies are essential for

Neuralink to be approved and for it to be incorporated into the development

of future neurosurgical operations (Fiani et al., 2021).

According to a 2022 article, The Physicians Committee for

Responsible Medicine has expressed concerns regarding the treatment of

monkeys used in Neuralink's research, claiming that the experiments

caused many monkeys to suffer from "chronic diseases, paralysis, and

severe psychological side effects." Furthermore, a Reuters report revealed

that Neuralink has been placed under investigation by the government for

prospective animal welfare offenses and has been subjected to employee

controversy over its animal testing program.

Based on their website, Neuralink announced that they are now

accepting applications for their First-in-Human Clinical Trial. Those with

quadriplegia caused by cervical spinal cord injury or amyotrophic lateral

sclerosis (ALS) may be eligible for the six-year trial, which includes 18
months of at-home and clinic visits followed by five years of follow-up visits

(Korn, 2023). Those interested can register for the patient registration on

Neuralink's website. They also added the PRIME Study (short for Precise

Robotically Implanted Brain-Computer Interface) that aims to evaluate the

safety of their implant (N1) and surgical robot (R1), as well as the initial

functionality of their BCI for allowing people with paralysis to control

external devices with their thoughts. Despite the approval of FDA,

according to the news agency, Paul and Singh (2023) emphasized safety

concerns related to the implant's lithium battery and potential overheating,

questions about whether the implant's small wires might be transferred to

other parts of the brain, and that the device's components cannot be

omitted without damaging brain tissue. Neuralink refuses to comment on its

clinical trial plans.

In the words of Regalado (2020), Musk considers that individuals

should link themselves to computers in an effort to continually keep up with

artificial intelligence. He went on to say that it's critical to figure out how we

can survive with advanced AI, reaching some AI symbiosis, and that the

world's future is determined by the collective desire of the people on the

planet. That may be the most significant accomplishment of a technology

like the Neuralink.

A. Discuss the potential for cognitive augmentation and human enhancement.

Cognitive augmentation and human enhancement involve the use of

technology, drugs, or interventions to improve human cognitive abilities and

performance. This area has become increasingly popular due to advancements in


neuroscience and artificial intelligence. While there are potential benefits, there are

also ethical considerations.

1. Benefits of Cognitive Augmentation:

a) Improved Cognitive Abilities: Techniques that augment cognition have

the potential to boost memory, attention, problem-solving, and overall

cognitive abilities. For instance, brain-computer interfaces (BCIs) have

shown promise in enhancing memory and attention in individuals with

cognitive impairments(Fregni et al., 2005).

b) Enhanced Learning and Training: Cognitive augmentation techniques can

improve the process of learning and training, leading to faster acquisition of

new skills. Virtual reality (VR) and augmented reality (AR) technologies have

been used to enhance training outcomes in various fields, such as surgery

(Seymour et al., 2002) and sports(Cochran et al., 2014).

2. Ethical Concerns:

a) Equity and Accessibility: The issue of equity and accessibility is a

significant concern when it comes to cognitive augmentation. If only certain

individuals have access to cognitive enhancements, it could worsen

existing social inequalities and create divides within society (Savulescu &

Bostrom, 2009). It is essential to prioritize equal access to cognitive

enhancements to prevent the further widening of socioeconomic gaps.

b) Personal Autonomy and Authenticity: The use of cognitive augmentation

raises important questions about personal autonomy and the genuineness

of human experiences. Some argue that enhancing cognitive abilities can


undermine individual autonomy by influencing their thoughts and

decision-making processes (Bostrom & Sandberg, 2009). Additionally,

concerns arise about the authenticity of accomplishments made with the

assistance of cognitive enhancements (Earp & Sandberg, 2015).

3. Limitations and Risks:

a) Long-term Effects and Unknown Consequences: The long-term

consequences and possible outcomes of cognitive augmentation

techniques remain uncertain. It is crucial to assess the potential risks and

unintended effects associated with these interventions. For instance, using

cognitive-enhancing drugs like methylphenidate (Ritalin) for non-medical

purposes could have lasting impacts on cognition, emotions, and social

aspects (Repantis et al., 2010).

b) Ethical Implications: There are various ethical considerations associated

with cognitive augmentation, including consent, safety, privacy, and the

potential for misuse. It is necessary to establish clear guidelines and

regulations to address these concerns and protect individuals' rights and

well-being (Greely et al., 2008).

In summary, the potential advancements in human cognition and performance

through cognitive augmentation and human enhancement are promising. However, it

is vital to address ethical issues, ensure fair availability, and investigate the long-term

consequences in order to responsibly develop and introduce these interventions.

B. Enhancing human capabilities through brain-computer interfaces (BCIs)

raises profound ethical and philosophical implications:


1. The integration of BCIs with the human mind raises concerns about

personal autonomy and identity. There is a need to examine the extent to

which individuals maintain control over their own thoughts and actions when

incorporating technology into their cognitive processes (Müller et al., 2017).

These considerations highlight the ethical importance of safeguarding

personal agency and preserving individuality.

2. When it comes to BCIs, privacy and data security are important

considerations due to the sensitive nature of the neural data collected and

analyzed. As advancements in neurotechnologies continue, it is crucial to

implement rigorous regulations and safeguards to protect individuals from

unauthorized access, potential misuse, and discrimination based on their

neural data (Yuste et al., 2017). It is essential to protect privacy rights and

ensure data security in order to maintain trust and prevent any potential

harm.

3. The fair access and equitable distribution of BCIs must be considered

during their creation and deployment. If BCIs are only accessible to a select

group of privileged individuals, it could worsen social inequalities and create

a "neurodivide" between those with improved cognitive abilities and those

without (Prescott et al., 2013). It is crucial from an ethical standpoint to

ensure equal opportunities and prevent societal fragmentation.

4. The issue of informed consent and risk assessment is important in the

context of BCIs. Users need a clear understanding of the potential

advantages and disadvantages of adopting BCIs in order to make informed

choices. Furthermore, it is crucial to create thorough evaluation frameworks


that can assess the risks and benefits of BCIs, promoting transparency and

accountability in the advancement and utilization of this technology (Bostrom

& Sandberg, 2009).

In summary, the ethical and philosophical consequences of augmenting

human abilities through BCIs involve concerns related to personal freedom, sense of

self, keeping information private, equal opportunity, fairness, obtaining informed

consent, and assessing potential risks. It is important to thoroughly examine these

subjects to ensure the responsible advancement and use of BCIs, while aiming for

societal advantages without disregarding important values and beliefs.

A. Identify the technical challenges faced by Newlink and similar companies.

Neuralink, alongside other companies that are developing brain-computer interface

(BCI) technologies, encounters numerous technical obstacles:

1. Miniaturization of Implants: One significant technical obstacle that Neuralink

and other BCI companies encounter is the downsizing of implantable devices.

It is crucial for the implant to be compact enough to be inserted into the brain

without causing considerable harm or inflammation. Musk et al. (2019) state

that attaining a small size for the device is vital for the successful placement.

2. Biocompatibility and Longevity: Another difficulty is guaranteeing the

prolonged compatibility and durability of the implanted device within the brain.

It is crucial for the device to endure the harsh biological conditions and retain

its effectiveness for an extended duration. Stieglitz et al. (2018) emphasize

the importance of utilizing materials that possess superior biocompatibility and

implementing resilient methods of encapsulation to tackle this challenge.


3. Neural Recording and Stimulation Resolution: Obtaining precise recordings

and stimulation of neurons at high resolutions is a difficult task. The device

must possess the ability to accurately detect and stimulate individual or groups

of neurons in order to understand and evoke specific brain functions. A recent

review by Obaid et al. (2018) emphasizes the significance of developing neural

interfaces with a large number of channels and superior signal-to-noise ratios

to address this challenge effectively.

4. Wireless Communication: Neuralink, together with other companies, is

working on creating a dependable and effective wireless connection between

the implanted device and external devices or networks. This wireless

connection should be able to securely transmit large amounts of neural

information with very little delay in communication. Musk and colleagues

(2019) stress the importance of a high-capacity wireless data transfer in their

study.

5. Data Processing and Analysis: Another technical hurdle is the handling of the

vast quantities of neural data obtained through implanted devices. To make

sense of this data and convert it into useful information or actions, it is

necessary to create machine learning algorithms and computational models.

Hochberg et al. (2020) emphasize the importance of developing advanced

computational methods for real-time interpretation of neural activity.

B. Limitations of current Brain-Computer Interface (BCI) technology:

1. Signal quality and reliability: One of the main drawbacks of BCI technology is

the insufficient quality and dependability of the brain signals obtained. These

signals are usually feeble and susceptible to different types of interference,


including electromyographic signals from muscles and external environmental

noise. Consequently, this can result in imprecise and unreliable detection of the

intended brain activity, ultimately impacting the overall effectiveness of BCIs

(Kübler and Müller-Putz, 2008).

2. Invasive techniques: According to Lebedev and Nicolelis (2017), invasive

techniques involve the insertion of electrodes into the brain, offering direct

access to brain signals. However, this method comes with inherent risks such

as infections, tissue damage, and the need for surgical procedures, thereby

restricting their practicality and widespread application.

3. Lack of standardization: The absence of standardization in signal processing

techniques, feature extraction methods, and classification algorithms across

different BCI systems creates challenges when comparing and replicating

results, which ultimately hinders the progress and widespread use of BCI

technology (Müller-Putz et al., 2015).

4. Limited communication bandwidth: The current state of brain-computer

interface (BCI) technology is limited in terms of communication bandwidth. BCIs

rely on identifying certain brain patterns or signals to control external devices or

communicate. However, the capacity for transmitting information between the

brain and the external world is constrained. As a result, the speed and quantity

of data that can be transmitted is restricted, which poses challenges for BCIs in

performing complex or real-time tasks (Wolpaw et al., 2002).

5. Adaptation and individual differences: According to Vidaurre and Blankertz

(2010), the need for training and calibration in BCIs arises from the necessity to

adapt to the unique brain signals of each individual user. The presence of
variations in brain signals among individuals and their fluctuations over time,

such as those caused by fatigue or emotional state, impact the reliability and

accuracy of BCI performance. Consequently, personalized calibration is

required, which limits the ease of use and general applicability of BCI

technology.

A. Explore ethical concerns related to brain-computer interfaces

Modern technologies like brain-computer interfaces (BCIs) have immense

potential to improve human skills, but they also present serious ethical

questions. The potential for privacy violation is one key worry. BCIs have the

ability to access and analyse neural data, which may contain extremely private

details about a person's thoughts, feelings, and intentions. Inappropriate use of

this data could result in major invasions of a person's privacy if it is not

adequately controlled because it could be accessed, shared, or used against

their will. As these technologies develop, it becomes increasingly difficult to

strike a balance between the advantages of BCIs and safeguarding users'

privacy.

Brain-computer interfaces (BCI) present ethical concerns related to

manipulation and coercion, as they can potentially be misused for mind control

and influencing individuals' thoughts and decisions, infringing on their

autonomy. Moreover, the accessibility of advanced BCI technology may create

disparities, where those with greater access gain advantages in communication,

education, or employment, exacerbating existing inequalities. In medical

contexts, issues of consent and informed decision-making arise, with patients

potentially facing pressure from medical professionals or loved ones to undergo

BCI procedures without fully understanding the long-term risks.


To address these ethical concerns, it is essential to implement thoughtful

regulation, ensure transparency, and engage in ongoing ethical discussions

surrounding BCI research and applications. This approach will help safeguard

individuals' autonomy, prevent misuse, and ensure that BCIs are used for the

benefit of both individuals and society as a whole. Ethical considerations must

remain at the forefront as BCIs continue to evolve and become more integrated

into our lives.

B. Discuss privacy, security, and data ownership issues

Privacy, security, and data ownership are prominent concerns in the

development and utilization of brain-computer interfaces (BCIs). Privacy

emerges as a significant issue since BCIs have the potential to access an

individual's most personal thoughts and emotions. Unauthorized access to such

sensitive data could result in unprecedented intrusions into one's personal life.

Therefore, it is imperative to establish protective measures that ensure the

confidentiality of BCI data and guarantee that it is only accessed with explicit

user consent. Additionally, there is a looming threat of data exposure or hacking

wherein malicious actors might intercept or manipulate the neural signals

exchanged between the brain and computer potentially leading to catastrophic

consequences.

Furthermore, security takes precedence in the context of BCIs. Ensuring both

hardware and software components' security for BCIs is vital to prevent

unauthorized access, tampering or manipulation. Weak security measures

could render BCIs susceptible to cyberattacks compromising not only an

individual's data but also their physical well-being if they control medical

devices or other critical systems. Thus implementing robust encryption,


authentication and intrusion detection mechanisms becomes essential for

safeguarding BCI integrity along with its managed data.

Lastly, determining rightful ownership of produced BCI-data raises legal &

ethical challenges making this aspect intricate within this realm. It is imperative

then that clear guidelines & regulations define rights & responsibilities regarding

ownership issues; individuals should retain autonomy over deciding how their

neural information gets employed shared monetized etc.. Striking a delicate

balance between fostering innovation while upholding individual rights will be

pivotal in shaping future societal impacts from these technologies - which must

remain at forefronts during continued developments going forward.

C. Consider the impact of CBI technology on society at large

Brain-computer interface (BCI) technology has the potential to revolutionize

multiple facets of society. In healthcare, BCIs offer a lifeline to individuals with

severe disabilities, enabling them to communicate and interact with the world in

unprecedented ways. People with conditions like locked-in syndrome can regain

some control over their lives by using BCIs to operate computers, robotic limbs,

or communicate through thought alone, significantly improving their quality of

life.

Beyond healthcare, BCIs could reshape education and workforce

development. They may enhance learning and training by enabling direct

brain-to-computer interactions, potentially making learning more efficient. In the

workforce, BCIs could increase efficiency and precision in tasks, but they also

raise ethical questions about privacy and access disparities.


Lastly, BCIs could create new realms of human augmentation and

entertainment, allowing individuals to control virtual environments and play

games using their thoughts. While this offers exciting possibilities, concerns

about addiction, privacy, and disconnection from the physical world emerge.

BCIs hold transformative potential in healthcare, education, and

entertainment. Striking a balance between harnessing their benefits and

addressing ethical and social concerns will be crucial as we integrate BCIs into

our daily lives.

A. Predict the potential advancements and applications of Neuralink

technology in the near and distant future

Neuralink is one of Elon Musk's ambitious technological plans of

advancement as he tries to bridge the huge gap between AI/technology and

human capabilities. This potentially advanced technology focuses on how the

brain can control technology using thoughts and the conductor that will connect

the brain activity and any compatible technology is the coin-sized chip that will

be planted on the human brain, which the chip wiring can be connected to

millions of blood vessels on the brain. Elon Musk’s disposition regarding this

groundbreaking plan is to make the common way of living more convenient with

technology. It is a huge leap for researchers and Elon Musk to facilitate this kind

of invention that can only be seen in Sci-Fi movies and the possible usage of the

device in the future.

According to Medium (2022), Neuralink can expand human potential soon,

focusing on our cognitive abilities. The technology will assist us in limiting human
error that causes most problems throughout the world’s history. New-found

heights of intelligence will be reached by the use of Neuralink. In addition, in the

field of education, the usage of the invention will improve how educators will

teach students and deliver information effectively. As the current educational

system in the world focuses on the concept of a “one-size-fits-all” approach

which is not currently effective, the device will provide educators with accurate

information about each of the students to offer them a specialized and tailored

curriculum that will fit the individual needs of each learner.

In the area of medicine, Neuralink also has the promise to elevate the

prevention and treatment of several diseases, particularly in the region of the

brain. Based on a literature review by Fiani et al. (2021), the invention will be a

future contribution to the field of neurosurgery to classify and prevent the

reoccurrence of brain tumors. Research supports this notion as they recently

installed Neuralink in the brain of a mouse whose brain tumor has been removed

and replaced the device on the same location of the tumor to detect possible

movements of the brain regarding the reoccurrence of the tumor. This data

proves that Neuralink has the potential to detect the reoccurrence of the

diseases as well as other types of cancer and to give patients a long life

expectancy.

According to Hernandez (2023), it will also have great lengths of improvement

in communication and accessibility. This groundbreaking advancement holds

immense promise for those facing mobility constraints, paralysis, or speech

impediments, offering them newfound avenues for self-expression and social

interaction. By harnessing the power of brain-computer interfaces, Neuralink's


innovation has the potential to enable people to express their thoughts and

desires effortlessly, connect with others on a profound level, and engage in a

wide array of activities with unprecedented efficiency.

B. Consider regulatory and legal frameworks that may develop

In the exciting world of neural interface technology, where companies like

Neuralink are pushing the boundaries, we're entering a phase where rules and

regulations are becoming crucial. These guidelines are necessary to deal with

the special challenges posed by brain-machine interfaces. These issues touch

on things like making sure people understand what they're getting into,

safeguarding their private brain data, and ensuring that everyone has a fair shot

at accessing these innovations. It's all about ensuring that Neuralink's

groundbreaking technology is introduced to society responsibly and ethically.

According to JusCurpos (2023), there are challenges and legal

implementations to be faced to ensure that the usage of the device doesn’t cross

the ethical and legal boundaries of the consumer. One of the biggest concerns is

privacy and data protection, which is the right to protect the user’s neural activity

and data. The law must establish clear boundaries and regulations concerning

how the data will be used and how it can be accessed and stored. Another

concern would be consumers’ intellectual property rights, which focus on the

ideas and creative discoveries made by the consumer that can be detected by

the device and have the possibility to be stolen.

Another legal framework to be considered is liability. Based on Lexology

(2020), Neuralink's implantable device raises questions about who would be

liable in case of any harm caused by the device. It is to be considered whether


the device has an influence on the person’s harmful actions or whether it is the

person’s free will to do such things without the intervention of the implanted

device. However, legal consultants impose that the company producing the

device and the seller companies from which the end consumers/users have

purchased this device may be held liable from the aspect of concrete outcomes

of the actions.

Neuralink’s animal trials have been already criticized due to its manhandling.

However, their ambitious plan of pushing 10 patients has been pushed back by

the FDA due to past issues of animal testing and safety concerns. This proposal

has been rejected due to safety concerns and can be a reflection that legal

implementations must be tightly regulated in order to facilitate test trials that are

not overcrossing the line of moral and ethical standards (Reuters, 2023).

A. Summarize key findings and insights

Brain-Computer Interfaces (BCIs) are advanced technologies with the

potential to assist non-communicative or paralyzed individuals by directly

detecting brain activity and providing real-time feedback. Neuralink, founded by

Elon Musk, is developing implantable BCIs like "The Link" to restore mobility for

people with paralysis and spinal cord injuries. However, BCIs raise ethical and

safety concerns, including the risk of harm, infections, and societal issues

related to autonomy, privacy, and cost. Despite these challenges, BCIs hold

promise for enhancing the lives of individuals with motor impairments. Neuralink,

the groundbreaking neurotechnology company founded by Elon Musk, is at the

forefront of advancing neuroscience and neuroengineering. Their ambitious goal

is to develop an implanted brain-machine interface that can significantly improve


the lives of individuals afflicted with neurological disorders and spinal cord

injuries. These brain-computer interfaces hold promise for diagnosing and

treating a wide range of conditions, from epilepsy to Alzheimer's disease, by

identifying brain activity variations.

Neuralink's technology has demonstrated the potential to restore lost motor

and sensory functions, enhance cognitive abilities, and even help individuals

with conditions like obesity, autism, depression, and schizophrenia. Despite

initial setbacks and concerns over safety and animal welfare, Neuralink has

received FDA approval for its clinical trials, offering hope to those in need. While

the technology's implications are vast, experts caution that extensive testing and

ethical considerations must guide its development to ensure both safety and

efficacy. Nonetheless, Neuralink represents a transformative step toward a

future where humans seamlessly interface with computers, coexisting with

advanced AI, and potentially reshaping the boundaries of human capability.

B. Offer recommendations for further research or policy development.

To ensure to navigate this uncharted territory responsibly, it is essential to

double down on further research and thoughtful policy development. When it

comes to research, the top priorities should be ensuring the safety and

effectiveness of BMIs, and making them accessible to as many people as

possible. Imagine a world where individuals with disabilities can harness the

power of BMIs to regain lost functions. It also needs to keep a close eye on the

ethical side of things; privacy, consent, and the potential for misuse are

important considerations. Moreover, the user experience should be smooth and

comfortable, like using any other piece of technology we rely on daily. On policy,
it's crucial that we collaborate closely with regulatory agencies to establish clear

rules for BMI development and usage. Privacy protection is another area where

we need strong policies in place to safeguard users' neural data. Ensuring that

informed consent is a cornerstone of BMI procedures is essential given that

we're talking about a technology that interfaces directly with the human brain.

And cybersecurity should be top-of-mind; it is also needed to protect these

interfaces from potential hacking or unauthorized access. Ultimately, it's about

responsible innovation and thoughtful governance to ensure that this incredible

technology serves humanity's best interests and doesn't stray into the

boundaries of ethics and moral standards.

REFERENCES

Barton, L. (2021, September 19). Tracing history of neuralink. Retrieved on


September 28, 2023 from
https://medium.com/@lauren.barton/tracing-the-history-of-neuralink-b93354e
9a504

Becher, B. (2023). What Is Neuralink? What We Know So Far. | Built In.


Builtin.com. https://builtin.com/hardware/what-is-neuralink

Bostrom, N., & Sandberg, A. (2009). Cognitive enhancement: methods, ethics,


regulatory challenges. Science and Engineering Ethics, 15(3), 311-341.

Burwell, S., Racine, E., & Sample, M. (2017). Ethical aspects of brain computer
interfaces: A scoping review. BMC Medical Ethics, 18:60. doi:
10.1186/s12910-017-0220-y

Capoot, A. (2022, December 1). Elon Musk shows off updates to his brain chips
and says he’s going to install one in himself when they are ready. CNBC.
https://www.cnbc.com/2022/12/01/elon-musks-neuralink-makes-big-claims-bu
t-experts-are-skeptical-.html

Capoot, A. (2023, May 26). Elon Musk’s brain implant company Neuralink
announces FDA approval of in-human clinical study. CNBC.
https://www.cnbc.com/2023/05/25/elon-musks-neuralink-gets-fda-approval-fo
r-in-human-study.html

Cochran, D., Reinsch, B., & Webb, M. (2014). Cognitive augmentation in sports:
a framework for giftedness. High Ability Studies, 25(1), 43-56.
Dixit, P. (2023, May 26). Elon Musk gets approval to put computer chip in human
brains: Know all about neuralink. Retrieved on September 28, 2023 from
https://www.google.com/amp/s/www.businesstoday.in/amp/technology/news/
story/elon-musk-gets-approval-to-put-computer-chip-in-human-brains-know-a
ll-about-neuralink-382898-2023-05-26

Earp, B. D., & Sandberg, A. (2015). The ethics of human cognitive enhancement.
In The Oxford Handbook of Neuroethics (pp. 429-445). Oxford University
Press.

Elon Musk unveils pig with chip in its brain. (2020, August 29). BBC News.
https://www.bbc.com/news/world-us-canada-53956683

Fiani, B., Reardon, T., Ayres, B., Cline, D., & Sitto, S. R. (2021). An Examination
of Prospective Uses and Future Directions of Neuralink: The Brain-Machine
Interface. Cureus, 13(3). https://doi.org/10.7759/cureus.14192

FindLight. (2023, March 15). Neuralink technology: Brief introduction. Retrieved


on September 28, 2023 from
https://www.findlight.net/blogg/neuralink-technology

FitzGerald, J. (2023, May 26). Neuralink: Elon Musk’s brain chip firm wins US
approval for human study. BBC News.
https://www.bbc.com/news/health-65717487
Fregni, F., Boggio, P. S., Nitsche, M., Bermpohl, F., Antal, A., Feredoes, E., ... &
Pascual-Leone, A. (2005). Anodal transcranial direct current stimulation of
prefrontal cortex enhances working memory. Experimental brain research,
166(1), 23-30.
Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P.,
& Farah, M. J. (2008). Towards responsible use of cognitive-enhancing drugs
by the healthy. Nature, 456(7223), 702-705.
Hart, R. (n.d.). Elon Musk’s Neuralink Wants To Put Chips In Our Brains — How
It Works And Who Else Is Doing It. Forbes. Retrieved October 3, 2023, from
https://www.forbes.com/sites/roberthart/2023/06/05/elon-musks-neuralink-wa
nts-to-put-chips-in-our-brains---how-it-works-and-who-else-is-doing-it/?sh=68
3c5a4bbabb
Hashmi, M. (2023, April 3). Neutral on Neuralink: the disadvantages and benefits
of upcoming neurotechnology. Medium.
https://medium.com/@mariamnhashmi/neutral-on-neuralink-the-disadvantag
es-and-benefits-of-upcoming-neurotechnology-ec7f93a4f748
Hochberg, L., et al. (2020). Neurotechnologies for Human Cognitive
Augmentation: Current State and Future Prospects. Frontiers in
Neuroscience, 14, 280. doi: 10.3389/fnins.2020.00280
Korn, J. (2023, September 20). Neuralink, Elon Musk’s brain implant startup, set
to begin human trials | CNN Business. CNN.
https://edition.cnn.com/2023/09/20/tech/musk-neuralink-human-trials/index.ht
ml#:~:text=Those%20with%20quadriplegia%20due%20to
Levy, R. (2022, December 6). Exclusive: Musk’s Neuralink faces federal probe,
employee backlash over animal tests. Reuters.
https://www.reuters.com/technology/musks-neuralink-faces-federal-probe-em
ployee-backlash-over-animal-tests-2022-12-05/
Levy, R., Taylor, M., Sharma, A., & Levy, R. (2023, May 26). Elon Musk’s
Neuralink wins FDA approval for human study of brain implants. Reuters.
https://www.reuters.com/science/elon-musks-neuralink-gets-us-fda-approval-
human-clinical-study-brain-implants-2023-05-25/
Moore, S. (2023, June 2). Elon Musk’s Neuralink “brain chips” cleared for 1st
in-human trials. Livescience.com.
https://www.livescience.com/health/neuroscience/elon-musks-neuralink-brain
-chips-cleared-for-1st-in-human-trials
Müller, V. C., Caviola, L., Kübler, A., & Biller-Andorno, N. (2017). Ethical
considerations on communication via brain-computer interfaces. Neuroethics,
10(1), 11-16.
Musk, E., et al. (2019). An integrated brain-machine interface platform with
thousands of channels. Journal of Medical Internet Research, 21(10),
e16194. doi: 10.2196/16194
Musk’s Neuralink to start human trial for brain implant chip. (2023, September
19). Reuters.
https://www.reuters.com/technology/musks-neuralink-start-human-trials-brain
-implant-2023-09-19/
Neuralink’s First-in-Human Clinical Trial is Open for Recruitment | Blog. (n.d.).
Neuralink. Retrieved September 19, 2023, from
https://neuralink.com/blog/first-clinical-trial-open-for-recruitment/
Neuralink’s Milestone: FDA Approval Signals New Era. (2023, May 29).
Ttconsultants.com.
https://ttconsultants.com/a-step-forward-for-brain-computer-interfaces-neurali
nks-fda-approval-sets-the-stage-for-a-new-era/
Nicolas-Alonso, L. & Gomez-Gil, J. (2012). Brain computer interfaces, a review.
Sensors, 12. doi: 10.3390/s120201211
Obaid, A. L., et al. (2018). Brain-Machine Interfaces: From Basic Science to
Neuroprostheses and Neurorehabilitation. Physiological Reviews, 98(1),
427-512. doi: 10.1152/physrev.00001.2017
Paul, K., & Singh, M. (2023, June 4). Elon Musk’s brain implant company is
approved for human testing. How alarmed should we be? The Guardian.
https://www.theguardian.com/technology/2023/jun/04/elon-musk-neuralink-ap
proved-human-testing-concern
Physicians Committee’s Response to Neuralink’s Nov. 30, 2022 “Show and Tell.”
(2022). Physicians Committee for Responsible Medicine.
https://www.pcrm.org/ethical-science/animals-in-medical-research/physicians
-committees-response-neuralinks-nov-30-2022-show-and-tell
Physicians Committee’s Statement on Neuralink Reportedly Receiving Approval
for Human Clinical Trials From the U.S. Food and Drug Administration. (n.d.).
Physicians Committee for Responsible Medicine.
https://www.pcrm.org/news/news-releases/physicians-committees-statement-
neuralink-reportedly-receiving-approval-human
Prescott, T. J., Diamond, M. E., Wing, A. M., & Wilson, S. P. (2013). Action
Systems: Motor Control, Reinforcement, and Value-Based Decision Making
Through BCI. Communication with Noninvasive Brain-Computer Interfaces,
235-264.
Regalado, A. (2020, August 30). Elon Musk’s Neuralink is neuroscience theater.
MIT Technology Review.
https://www.technologyreview.com/2020/08/30/1007786/elon-musks-neuralin
k-demo-update-neuroscience-theater/
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010). Modafinil and
methylphenidate for neuroenhancement in healthy individuals: A systematic
review. Pharmacological Research, 62(3), 187-206.
Reuters. (2022, December 7). Neuralink: What you need to know about Elon
Musk’s brain chip company. Retrieved on September 28, 2023 from
https://www.reuters.com/technology/what-does-elon-musks-brain-chip-compa
ny-neuralink-do-2022-12-05/
Savulescu, J., & Bostrom, N. (2009). Human enhancement ethics: the state of
the debate. The Ethical Journal of the Harvard Medical School, 5(1), 13-15.
Sekuterski, D. (n.d.). FDA approves neuralink for human trials: Balancing
innovation with safety concerns. Retrieved on September 28, 2023 from
https:// www.wolfandco.com/resources/insights/fda-approves-neuralink-for
-human-trials-balancing-innovation-with-safety-concerns
Seymour, N. E., Gallagher, A. G., Roman, S. A., O'Brien, M. K., Bansal, V. K.,
Andersen, D. K., & Satava, R. M. (2002). Virtual reality training improves
operating room performance: results of a randomized, double-blinded study.
Annals of Surgery, 236(4), 458-464.
Sood, G., & Mishra, S. (2020). Neuralink Technology - The Merge Between AI
and Humans. Www.academia.edu.
https://www.academia.edu/50645016/Neuralink_Technology_The_Merge_Bet
ween_AI_and_Human
Stieglitz, T., et al. (2018). Brain-Machine Interfaces Fabricated from Highly
Efficient Neural Probes with Integrated 2D-Materials. Advanced Functional
Materials, 28(24), 1707253. doi: 10.1002/adfm.201707253
TT Consultants. (2023, May 29). A step forward for brain-computer interfaces:
Neuralink’s FDA approval sets the stage for a new era. Retrieved on
September 28, 2023 from
https://ttconsultants.com/a-step-forward-for-brain-computer-interfaces-neurali
nks-fda-approval-sets-the-stage-for-a-new-era/
US Government Accountability Office. (2022, September 8). Science & tech
spotlight: Brain-computer interfaces. Retrieved on September 28, 2023 from
https://www.gao.gov/products/gao-22-106118
Wakefield, J. (2021, April 9). Elon Musk’s Neuralink “shows monkey playing
Pong with mind.” BBC News.
https://www.bbc.com/news/technology-56688812
Yuste, R., Goering, S., Arcas, B. A., Bi, G., Carmena, J. M., Carter, A., ... &
Zador, A. (2017). Four ethical priorities for neurotechnologies and AI. Nature,
551(7679), 159-163.

You might also like